Diisopropylethylamine → HCID 86730283, compound
Reaction equation
Cl[C:2]1[N:7]=[C:6]([N:8]2[C@@H:12]([CH:13]([CH3:15])[CH3:14])[CH2:11][O:10][C:9]2=[O:16])[CH:5]=[CH:4][N:3]=1.[F:17][C:18]1[CH:33]=[CH:32][C:21]([O:22][C:23]2[N:28]=[CH:27][C:26]([C@@H:29]([NH2:31])[CH3:30])=[CH:25][CH:24]=2)=[CH:20][CH:19]=1.CCN(C(C)C)C(C)C>CS(C)=O>[F:17][C:18]1[CH:19]=[CH:20][C:21]([O:22][C:23]2[N:28]=[CH:27][C:26]([C@@H:29]([NH:31][C:2]3[N:7]=[C:6]([N:8]4[C@@H:12]([CH:13]([CH3:15])[CH3:14])[CH2:11][O:10][C:9]4=[O:16])[CH:5]=[CH:4][N:3]=3)[CH3:30])=[CH:25][CH:24]=2)=[CH:32][CH:33]=1Participants
5
Conditions
- Temperature
- 107.5 °C
Procedure
To (S)-3-(2-chloropyrimidin-4-yl)-4-isopropyloxazolidin-2-one (28 mg, 0.116 mmol) was added (S)-1-(6-(4-fluorophenoxy)pyridin-3-yl)ethanamine (46.7 mg, 0.174 mmol), DMSO (0.6 ml) and Hunig's Base (0.071 ml, 0.406 mmol). The reaction was heated at 105-110° C. for 24 hours or until done by LCMS. The reaction was let cool, 0.5 ml of DMSO was added, filtered, purified by prep LC and lyophilized to give 7.1 mg of (S)-3-(2-((S)-1-(6-(4-fluorophenoxy)pyridin-3-yl)ethylamino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one as the TFA Salt. LCMS m/z 438.2 (M+H)+, Rt 0.82 min.
Workup
- temperatureThe reaction was let cool
- filtrationfiltered
- custompurified by prep LC
Sources & evidence
- ORD record
- ord-3f745b5d88dd484b9b8b6cb68707b0d5
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08957068B2
Reaction notes
Loading…